Towa Pharmaceutical Co., Ltd. (TYO: 4553)

Market Cap	161.46B
Revenue (ttm)	243.94B
Net Income (ttm)	15.78B
Shares Out	49.23M
EPS (ttm)	320.49
PE Ratio	10.23
Forward PE	10.28
Dividend	60.00 (1.82%)
Ex-Dividend Date	Mar 28, 2025

Volume	14,200
Average Volume	129,200
Open	3,310.00
Previous Close	3,300.00
Day's Range	3,305.00 - 3,350.00
52-Week Range	2,470.00 - 3,395.00
Beta	-0.09
RSI	64.02
Earnings Date	Feb 13, 2025

About Towa Pharmaceutical

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, devel...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 4,588
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4553

Financial Performance

In 2023, Towa Pharmaceutical's revenue was 227.93 billion, an increase of 9.13% compared to the previous year's 208.86 billion. Earnings were 16.17 billion, an increase of 634.80%.